Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for ANIK

Data valid for week beginning July 14, 2008

Ticker Company Name
ANIK   [News] Anika Therapeutics Inc
Company Profile
"Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair primarily in the United States, Europe, and Turkey. Its products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. The company's products include ORTHOVISC, a HA product used in the treatment of osteoarthritis in humans- AMVISC, AMVISC Plus, STAARVISC-II, and ShellGel, each an injectable ophthalmic viscoelastic HA product that are used in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation- Hyvisc that is used for the treatment of equine osteoarthritis- and INCERT, which is an HA based anti-adhesive for surgical applications. It is developing next generation osteoarthritis-joint health related products, which include Monovisc and Cingal- and ELEVESS, a family of aesthetic dermatology products for facial wrinkles, scar remediation, and lip augmentation. Anika Therapeutics sells its products through representatives, agents, and distributors. The company was founded in 1983 and is headquartered in Bedford, Massachusetts."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

ANIK Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for ANIK. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Anika Therapeutics Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $9.30
Volume Avg. 37810 shares
Industry Biotechnology
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? No

Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
Stock Financials
Profit Margin 16.40%
Operating Margin 18.41%
Debt-to-Equity .07%
P/E ttm 19.00
EPS ttm $0.470
EBITDA $7,120,000
Total Revenue $33,240,000
Market Cap $94,580
Annual Dividend $.00
Yield .000%
ROE 10.48%
Revenue Growth Rate Quarterly 39.30%
Earnings Growth Rate Quarterly 0.00%
Earnings Growth Rate Yearly 0.00%
Revenue Growth Rate Average 18.51%
Earnings Growth Rate Average 0.00%
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score Members Only


Latest News

Thu, 10 Jul 2008 23:10:45 Etc/GMTAnika Therapeutics Earnings Call scheduled for Wed, July 23 (CCBN)
Thu, 10 Jul 2008 21:27:00 Etc/GMTAnika Therapeutics Announces Date of Second Quarter 2008 Financial Results Conference Call (Business Wire)
Tue, 8 Jul 2008 16:00:00 Etc/GMTToday's 5-Star Movers (at Motley Fool)
Tue, 8 Jul 2008 11:15:00 Etc/GMTAnika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler (Business Wire)
Thu, 3 Jul 2008 09:11:21 Etc/GMTAnika Therapeutics: Building On Previous Success (at Seeking Alpha)
Mon, 30 Jun 2008 14:11:00 Etc/GMTAnika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe (Business Wire)
Sat, 10 May 2008 13:05:04 Etc/GMTANIKA THERAPEUTICS INC Financials (EDGAR Online Financials)
Wed, 7 May 2008 14:50:51 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Thu, 1 May 2008 13:00:00 Etc/GMTAnika Therapeutics Earnings Call scheduled for 9:00 am ET today (CCBN)
Thu, 1 May 2008 10:05:39 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex (EDGAR Online)
Wed, 30 Apr 2008 21:15:00 Etc/GMTAnika Therapeutics Reports Strong Revenue Growth for First Quarter 2008 (Business Wire)
Wed, 30 Apr 2008 11:08:11 Etc/GMTQ1 2008 Anika Therapeutics Earnings Release - After Market Close (CCBN)
Fri, 25 Apr 2008 15:42:00 Etc/GMTAnika Therapeutics Announces Date of First Quarter 2008 Financial Results Conference Call (Business Wire)
Mon, 7 Apr 2008 12:46:19 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right (EDGAR Online)
Wed, 12 Mar 2008 19:46:10 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 10-K, Annual Report (EDGAR Online)
Wed, 5 Mar 2008 21:55:26 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex (EDGAR Online)
Fri, 15 Feb 2008 14:50:10 Etc/GMTThursday's Biggest Stock Stars (at Motley Fool)
Wed, 6 Feb 2008 22:08:58 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princip (EDGAR Online)
Thu, 6 Dec 2007 21:07:35 Etc/GMT5 Top Micro-Cap Stocks (at Motley Fool)
Wed, 21 Nov 2007 22:23:04 Etc/GMTANIKA THERAPEUTICS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and E (EDGAR Online)
News provided by Yahoo! Finance